BioZen Limited
Developing the world’s first approved medical cure for moobs!
Status
IP Type
Patent
Time
–
Countries
Coverage
Method of use and formulation for gynecomastia.
Know more of this patent
This information is confidential, do not share or copy.
You can visit their website or
BioZen White Paper Prevail Partners Term Sheet Syneos Health Commercial Feasibility Study Paediatric Gynecomastia: Review of Pharmacological Treatments Tamoxifen for breast events induced by antiandrogens in patients with prostate cancer EAA clinical practice guidelines - gynecomastia evaluation and management
Under evaluation at least till: 1st of October 2023
KEEP REVIEWING